Bladder cancer incidence statistics
Bladder cancer incidence by gender and UK country
| Bladder cancer accounts for 3% of all new cancer cases in the UK, with around 2,800 new cases in females and around 7,600 new cases in males every year (2017-2019). |
Bladder cancer incidence by age
| Incidence rates for bladder cancer are highest in people aged 85 to 89 in the UK, with almost 3 in 20 (13%) of all new bladder cancer cases diagnosed in this age group (2017-2019). |
Bladder cancer incidence trends over time
| Bladder cancer incidence rates have decreased by more than two-fifths (42%) in the UK since the early 1990s and rates have decreased by around a seventh (15%) in the last decade (2017-2019). |
Bladder cancer incidence projections
| Bladder cancer incidence rates in the UK are projected to decrease by 14% between 2023-2025 and 2038-2040, with around 10,700 new cases each year by 2038-2040. |
Bladder cancer incidence rates (European age-standardised (AS) rates) in England in females are 47% higher in the most deprived quintile compared with the least, and in males are 23% higher in the most deprived quintile compared with the least (2013-2017).[1]
It is estimated that there are around 980 more cases of bladder cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile. around 370 of these cases are in females, and around 610 in males.
See also
Data table: Cancer incidence rates and excess cases by cancer type in England(link is external)
Incidence by deprivation for all cancer types combined
Bladder cancer mortality by deprivation (not directly comparable with incidence by deprivation)
Cancer incidence by deprivation for Scotland(link is external)
Cancer incidence by deprivation for Wales(link is external)
Cancer incidence by deprivation for Northern Ireland(link is external)
References
- Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011(link is external) . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.
About this data
Data is for England, 2013-2017, ICD-10 C21.
Last reviewed: 30 September 2020
An estimated 69,100 people who had been diagnosed with bladder cancer between 1991 and 2010 were alive in the UK at the end of 2010.[1]
See also
Find out more about the counting and coding of this data
References
- Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables(link is external). London: NCRAS; 2015.
About this data
Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C67.
Last reviewed: 27 July 2017
Statistics by cancer type
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
Citation
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or
Newsletter
Stay up to date by signing up to our cancer statistics and intelligence newsletter
Acknowledgements
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.